市場調查報告書
商品編碼
1218827
全球EEG市場:到2028年的預測-按產品(頻道),類型(影像,動態,常規),模式,應用,最終用戶和地理分析Electroencephalography Systems Market Forecasts to 2028 - Global Analysis By Product (Multichannel, 40-channel, 32-channel, 25-channel, 21-channel & 8-channel), Type (Video, Dynamic & Conventional), Modality, Application, End User & By Geography |
根據 Stratistics MRC,全球 EEG 市場將在 2022 年佔 7.7951 億美元,到 2028 年達到 11.6329 億美元,預測期內復合年增長率為 6.9%。
腦電圖設備用於監測大腦中的電信號。 然而,這些電信號非常微弱,因此需要使用放大器來增加電壓。該設備的讀數用於診斷各種神經系統疾病、睡眠障礙和監測麻醉下的患者。 該設備借助戴在患者頭皮上的電極收集腦電波讀數。 該設備主要用於醫院、診斷實驗室、門診手術中心等。
據 EMSP 稱,據說歐洲約有 900 萬人患有神經退行性疾□□病。 根據阿爾茨海默氏症協會的數據,大約有 650 萬 65 歲以上的美國人患有阿爾茨海默氏病。 此外,73%是75歲以上的老年人。
市場動態
促進因素
神經血管疾病患病率上升
癲癇、阿爾茨海默病、癡呆、帕金森病和多發性硬化症等神經系統疾病發病率的增加是市場增長的主要原因。 預計發達國家和發展中國家公眾對神經系統疾病和紊亂的認識將推動市場增長。 此外,增加政府對神經科學相關研發活動的資助也有望帶來有利可圖的增長。
抑制因素
低空間分辨率和無意義的結果
雖然 EEG 提供高時間分辨率,但空間分辨率很差。 即使是高時間分辨率的數據也可能不精確,因此被認為意義不大。 雖然其他技術可以顯示大腦活動區域,但 EEG 需要強大的解釋來總結和假設特定反應的活動區域。 然而,替代品的存在阻礙了市場的增長。
機會
老齡化社會比例增加
人口老齡化正在推動神經科學領域研發活動的增長。 由於設備技術的進步,越來越多地採用腦電圖設備在手術室也是市場增長的一個因素。
威脅
設備成本高
設置傳統 EEG 設備的成本高昂,並且缺乏熟練的專業人員來準確管理和操作設備,預計將阻礙預測期內的市場增長。 缺乏腦電圖保險報銷也被認為是一個市場挑戰。
COVID-19 的影響
COVID-19 的爆發擾亂了醫療保健行業,導致對遠程監控和患者參與解決方案的需求激增。 一些醫療保健機構似乎正在將患者監測推向家庭護理環境。 大流行進一步增加了對呼吸機的需求,例如用於建立 ICU 的呼吸器。 預計研究人員將評估機械通氣搶救療法對大腦的影響,以選擇針對冠狀病毒患者的治療方法。
獨立設備部分預計在預測期內最大
獨立設備部分預計將實現有利可圖的增長,因為它是最常用的 EEG 類型。 這些系統固定或嵌入在特定位置。 此類系統主要用於醫院,由硬件和軟件解決方案組成,使醫生能夠有效地解釋結果。 這些設備用於記錄大腦中的電活動。 這極大地促進了在此類環境中使用的獨立設備的激增。
預計在預測期內,醫院行業的複合年增長率最高。
由於遭受創傷性腦損傷、癲癇和其他神經系統疾病的患者數量不斷增加,預計在預測期內,醫院行業的複合年增長率最高。 醫院是該設備的主要最終用戶,因為他們需要為臨床和研究目的記錄節律和電活動,並詳細評估結果。 因此,由於患者流失率高和再入院率高,該細分市場佔據了市場主導地位。
市場份額最高的地區
由於醫療保健成本上升和包括癲癇在內的各種神經系統疾病患病率上升,預計亞太地區在預測期內將佔據最大的市場份額。 此外,隨著一些亞洲國家醫療基礎設施的迅速發展和消費者信心的提高,對先進腦電圖設備的需求預計將增長。 此外,新興國家對醫療保健基礎設施發展的日益重視也推動了該地區的增長。
複合年增長率最高的地區
由於神經系統疾病發病率增加和睡眠障礙患病率上升,預計北美在預測期內的複合年增長率最高。 先進的醫療保健基礎設施的存在、患者及其家人對早期診斷的高度認識以及高技能神經科醫生的存在有助於該地區的份額。
主要發展
2021年8月,美國領先的醫療器械解決方案公司Natus Medical宣布Natus新推出的XactTrode系列鉑金硬膜下電極用於癲癇手術監測的首次臨床試驗宣布完成成功案例
2021 年 2 月,Cadwell 宣布從 Ambu A/S 收購 Sleepmate 睡眠診斷傳感器。 30 多年來,Sleepmate 產品一直提供高質量、可靠的睡眠診斷傳感器解決方案,此次收購將 Sleepmate 的產品組合納入 Cadwell 用於實驗室和家庭測試的睡眠診斷解決方案。
2019 年 10 月,美國精密醫療產品和服務的全球領導者 Nihon Kohden 宣布了一款無線腦電圖儀 (EEG),主要用於快速評估無意識患者的腦電圖資訊。我們開始銷售耳機 VitalEEG .
本報告的內容
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一
According to Stratistics MRC, the Global Electroencephalography Systems Market is accounted for $779.51 million in 2022 and is expected to reach $1163.29 million by 2028 growing at a CAGR of 6.9% during the forecast period. Electroencephalography equipment is used to monitor the electrical signals of the brain. However, these electrical signals are very weak and thus, an amplifier is employed to magnify the voltage. The readings from device are used to diagnose various neurological disorders and monitor sleep disorders and patients under anaesthesia. The equipment works with the help of electrodes that are attached to the scalp of the patient to collect the reading of the brain wave. This equipment is mostly used in hospitals, diagnostic laboratories, ambulatory surgery centers, and others.
According to EMSP, approximately 9 million people in Europe are affected by neurodegenerative diseases. According to the data from the Alzheimer's Association, almost 6.5 million Americans aged 65 years and older are suffering from Alzheimer's. Seventy-three percent are of age 75 or older.
Market Dynamics:
Driver:
Rising prevalence of neurovascular disorders
Rising incidences of neurological diseases like epilepsy, Alzheimer's, dementia, Parkinson's diseases, multiple sclerosis is the primary reason for the growth of the market. The growing awareness among people about neurological diseases and disorders in developed and developing regions is expected to impel the market growth. Additionally, increased government funding for neuroscience-related R&D activities is anticipated to have lucrative growth.
Restraint:
Low spatial resolution and less meaningful results
While EEG offers a high temporal resolution, they deliver subpar results for spatial resolution. Even the data produced through the temporal resolution is inaccurate oftentimes and as such, can be considered less meaningful. Other techniques are able to display the active regions of the brain, while EEG necessitates the need for intense interpretation that would conclude and hypothesize the active regions for a specific response. However, presence of substitute products hinders the growth of the market.
Opportunity:
Increasing proportion of the aging population
Growing geriatric population has resulted in the growth of research and development activities in the neuroscience sector. In addition, technological advancements in the field of equipment increase in adoption of EEG equipment in surgery centers are the factors that contribute to the growth of the market.
Threat:
High cost associated with the equipment
The high cost associated with the setup of conventional EEG device, and the lack of skilled professionals to administer and operate the device in an accurate manner is expected to hinder the growth of the Market over the forecast period. Also, lack of reimbursement of electroencephalography procedures is projected to challenge the market.
COVID-19 Impact
The COVID-19 outbreak disrupted the healthcare industry with the demand for remote monitoring and patient engagement solutions soaring exponentially. Several healthcare facilities are likely to fuel their patient monitoring towards home care settings. The pandemic furthered the demand for ventilators, such as respiratory devices to set up ICUs. Researchers are projected to assess the effects of rescue therapies with ventilation on the brain to help select therapies for corona virus patients.
The standalone devices segment is expected to be the largest during the forecast period
The standalone devices segment is estimated to have a lucrative growth, due to it is the most commonly used type of EEGs. These systems are fixed or implanted at a particular place. Such systems are used mainly in hospital settings and consist of hardware and software solutions that allow physicians to interpret results efficiently. These devices are used to record electrical activities in the brain. This has largely contributed to the surge of standalone devices that are used in such settings.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the growing number of patients suffering from traumatic brain injuries, epilepsy, and other neurological disorders. Hospitals are primary end users of the devices because of their need to record the rhythm and electrical activity and evaluate the results in detail for clinical and research purposes. Thus, this segment dominated the market owing to the high patient turnaround and frequent readmissions.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to rise in healthcare expenditure, and surge in prevalence of various neurological disorders such as epilepsy and others. Moreover, rapidly developing healthcare infrastructure along with the rise in spending power in certain Asian countries is expected to support the demand for advanced EEG equipment. In addition, increasing focus on the development of healthcare infrastructure in developing countries propels the region growth.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to increasing incidences of neurological disorders, and the rising prevalence of sleep disorders. The presence of sophisticated healthcare infrastructure, high awareness levels amongst patients and their families regarding early diagnosis, and availability of highly skilled neuro physicians are some factors attributing to its large share.
Key players in the market
Some of the key players profiled in the Electroencephalography Systems Market include Medtronic Plc, Koninklijke Philips NV, Natus Medical Inc., Cadwell Industries Inc., Electrical Geodesics, Inc., BrainScope Co. Inc., Compumedics Ltd., NeuroWave Systems Inc., Advanced Brain Monitoring Inc., Micromed SPA, Elekta AB, Nihon Kohden America, Inc., Magstim EGI, Compumedics Ltd. and Noraxon U.S.A., Inc.
Key Developments:
In August 2021, Natus Medical, a leading provider of medical device solutions in the U.S, announced the completion of the first successfully performed clinical trial by using Natus' newly launched XactTrode family of platinum subdural electrodes which will be used for Epilepsy Surgical Monitoring.
In February 2021, Cadwell announced that it acquired the Sleepmate Sleep Diagnostic Sensors from Ambu A/S. Sleepmate products provide high-quality and reliable sleep diagnostic sensor solutions for more than 30 years and this acquisition will include the Sleepmate portfolio into Cadwell's sleep diagnostic solutions for both in-lab and at-home testing.
In October 2019, Nihon Kohden, a global leader in precision medical products and services in the U.S, launched VitalEEG wireless electroencephalogram (EEG) headset which was mainly designed for quick assessment of brain-wave information in case of unconscious patients.
Products Covered:
Types Covered:
Modality Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.